The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
Abstract b-AP15 and its derivatives block proteasome deubiquitinase (DUB) activity and have been developed and tested in the clinic as potential cancer therapeutic agents. b-AP15 induces apoptosis in cancer cells, but the underlying mechanisms are largely undefined. The current study focuses on stud...
Guardado en:
Autores principales: | You-Take Oh, Liang Deng, Jiusheng Deng, Shi-Yong Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/38f8016a0030447e8e7e8736ee71973b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
por: Xin Hua, et al.
Publicado: (2021) -
Puma and Trail/Dr5 pathways control radiation-induced apoptosis in distinct populations of testicular progenitors.
por: Mathieu Coureuil, et al.
Publicado: (2010) -
Deubiquitinase activity is required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress
por: Nancy N. Fang, et al.
Publicado: (2016) -
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
por: Shengzhe Zhang, et al.
Publicado: (2018) -
Proteasomal degradation of TRIM5alpha during retrovirus restriction.
por: Christopher James Rold, et al.
Publicado: (2008)